Home›Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox›Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox + Triamcinolone

Does Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox Interact with Triamcinolone?

Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox and Triamcinolone have a unknown drug interaction according to U.S. FDA drug labeling data. Corticosteroids: e.g., betamethasone budesonide ciclesonide dexamethasone fluticasone methylprednisolone mometasone triamcinolone ↓ elvitegravir ↓ cobicistat ↑ corticosteroids Coadministration with oral dexamethasone or other systemic corticosteroids that induce CYP3A may result in loss of therapeutic effect and development of resistance to elvitegravir. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox Class
Cytochrome P450 3A Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox and your doctor is considering prescribing Triamcinolone (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox(Stribild)+💊 Triamcinolone(Trianex)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Cytochrome P450 3A Inhibitor
Drug B class
—
Source
FDA drug label - elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate

What this means in plain English

Corticosteroids: e.g., betamethasone budesonide ciclesonide dexamethasone fluticasone methylprednisolone mometasone triamcinolone ↓ elvitegravir ↓ cobicistat ↑ corticosteroids Coadministration with oral dexamethasone or other systemic corticosteroids that induce CYP3A may result in loss of therapeutic effect and development of resistance to elvitegravir.

About Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox and Triamcinolone

Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox is a Cytochrome P450 3A Inhibitor. You may recognize them by the brand names Stribild and Trianex. Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox is taken by mouth. Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

FDA

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Elvitegravir Cobicistat Emtricitabine And Tenofovir Disoprox and Triamcinolone against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.